Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions

類似資料

• Combination Iron Chelation Therapy with Deferiprone and Deferasirox in Iron-Overloaded Patients with Transfusion-Dependent β-Thalassemia Major
  著者:: Karami, Hossein, 等
  出版事項: (2017)
• Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload
  著者:: Alavi, Samin, 等
  出版事項: (2014)
• Chelation Therapy with Oral Solution of Deferiprone in Transfusional Iron-Overloaded Children with Hemoglobinopathies
  著者:: Makis, Alexandros, 等
  出版事項: (2013)
• Deferasirox, an oral chelator in the treatment of iron overload
  著者:: I. Portioli
  出版事項: (2013-05-01)
• Iron Chelation Adherence to Deferoxamine and Deferasirox in Thalassemia
  著者:: Trachtenberg, Felicia, 等
  出版事項: (2011)